The effect of yokukansan and shoseiryuto on Atopic Dermatitis with itch and QOL disorders.-an explaratory research-

The effect of yokukansan and shoseiryuto on Atopic Dermatitis with itch and QOL disorders.-an explaratory research- - The effect of yokukansan and shoseiryuto on Atopic Dermatitis with itch and QOL disorders.-an explaratory research-

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008854

Enrollment

Registered

2012-09-10

Start date

2012-06-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis

Interventions

Patients takes yokukannsan three times a day (before breakfast, before supper, at bedtime ) for two weeks. Afterwards, we switch medicine to shoseiryuto. Patients takes shoseiryuto three times a day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Atopic Dermatitis

Exclusion criteria

Exclusion criteria: 1)Patients under the age of 20 2)When a doctor judged a patient not appropriate to join the research.

Design outcomes

Primary

Measure	Time frame
(1)questionnaire(VAS scale) sleepless, itch, jitteriness (2)SCORAD(Severity Scoring of Atopic Dermatitis) (3)DLQI(Dermatology Life Quality Index) (4)Blood test(LDH, eosino, TRAC, Liver function) We determine (1)-(4) at 0, 2 and 4 week.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026